---
title: "ARID1A"
date: 2023-05-12 00:00:00
layout: post
categories: Gene
summary: "## ARID1A Gene Information"
tags: ['ARID1A', 'ChromatinRemodeling', 'Cancer', 'Mutation', 'DrugResponse', 'Prognosis', 'GeneticInformation', 'SWISNFComplex']
---

## ARID1A Gene Information

### Gene Position and Pathology
- ARID1A (AT-rich interaction domain 1A) is a gene located on chromosome 1p36.11.
- It plays an essential role in chromatin remodeling through ATP-dependent SWI/SNF chromatin remodeling complexes.
- ARID1A mutations are frequently identified and contribute to the pathogenesis of multiple cancers, including gastric, colorectal, bladder, ovarian, and endometrial carcinomas.

### Gene Function
- ARID1A encodes a protein that forms a part of the SWI/SNF chromatin remodeling complex.
- It regulates gene expression, DNA damage repair, and chromatin organization.

### External IDs and Aliases
- Gene ID: 8289
- Genomic Location: Chromosome 1:2,285,201-2,398,286
- HGNC ID: HGNC:10702
- NCBI Entrez ID: 8289
- Ensembl ID: ENSG00000117748
- OMIM ID: 603024
- UniProtKB/Swiss-Prot ID: O14497
- Aliases: B120, C1orf4, DKFZp686J05112, MRD14, P270, SMARCF2

### Genetic Mutations
- AA Mutation List: [Click](http://www.ensembl.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=ENSG00000117748;r=1:2282152-2398286)
- Mutation type: Missense, nonsense, frameshift, splice
- dbSNP ID: rs121434358, rs121434355, rs121434354, rs121434357, rs149868424, rs587783871, rs786201005, rs765579718

### Somatic SNVs/InDels
- dbSNP ID: rs145572167, rs145491149, rs35893571, rs369169081, rs45558340, rs587781758, rs758576833, rs780018371, rs796263027, rs797044617, rs797044620, rs797044621, rs797044622

### Related Diseases
- ARID1A mutations are associated with several cancers, including gastric, colorectal, bladder, ovarian, and endometrial carcinomas.

### Treatment and Prognosis
- Patients with ARID1A mutations may respond differently to chemotherapy and immunotherapy compared to those without the mutation.
- The prognosis for patients with ARID1A-mutated tumors may vary depending on the cancer type and stage.

### Drug Response
- ARID1A mutations may impact response to chemotherapy and immunotherapy.
- Further studies are needed to determine the impact of ARID1A mutations on drug response.

### Related Papers
- Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532-1543. doi: 10.1056/NEJMoa1008433. PMID: 20942669.
- Fujimoto A, Furuta M, Shiraishi Y, et al. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer. Nat Genet. 2016;48(5):500-509. doi: 10.1038/ng.3547. PMID: 27064250.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**